Pharma stocks have gained investor interest as the Nifty Pharma index reaches new highs. Amid economic uncertainties, defensive sectors like pharma offer minimal risk. Notable picks include Lupin, Sun Pharma, and Dr Reddy’s. The sector saw significant foreign inflows, driven by the performance of the generic drug Revlimid.
‘Defensive’ pharma scales new peak as Street looks beyond high-growth plays
Date:
More like thisRelated
DC Circuit Finds Some FINRA Authority Violates Private Nondelegation Doctrine
The private nondelegation doctrine is getting an increasing amount...
DC Circuit Finds Some FINRA Authority Violates Private Nondelegation Doctrine
The private nondelegation doctrine is getting an increasing amount...
The Math on Mass Deportation Doesn’t Add Up
Flawed calculations and overlooked benefits show why Trump's immigration...